Literature DB >> 17294161

Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children.

H S Schaaf1, T C Victor, E Engelke, W Brittle, B J Marais, A C Hesseling, P D van Helden, P R Donald.   

Abstract

The aim of the study presented here was to determine the minimal inhibitory concentration of isoniazid for strains of isoniazid-resistant or multidrug-resistant Mycobacterium tuberculosis isolated from children in the Western Cape Province of South Africa. During the period March 2003-October 2005, 45 INH-resistant M. tuberculosis isolates (21 also rifampicin-resistant) were cultured from children less than 13 years of age. Drug susceptibility testing by the radiometric BACTEC 460 method found 11 isolates resistant at 0.1 microg/ml, 27 resistant at 0.2 microg/ml, and seven resistant at > or =5 microg/ml. Thus, the minimal inhibitory concentration of isoniazid for more than 80% of the isoniazid-resistant strains isolated from children in this study was relatively low and could be exceeded by high-dose (15-20 mg/kg) isoniazid regimens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17294161     DOI: 10.1007/s10096-007-0257-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  THE CLINICAL SIGNIFICANCE OF LOW DEGREES OF DRUG RESISTANCE IN PULMONARY TUBERCULOSIS.

Authors:  S M STEWART; J W CROFTON
Journal:  Am Rev Respir Dis       Date:  1964-06

2.  Successful treatment of advanced isonizid- and streptomycin-resistant pulmonary tuberculosis with ethionamide, pyrazinamide, and isoniazid.

Authors:  T L PETTY; R S MITCHELL
Journal:  Am Rev Respir Dis       Date:  1962-10

3.  Global incidence of multidrug-resistant tuberculosis.

Authors:  Matteo Zignol; Mehran S Hosseini; Abigail Wright; Catharina Lambregts-van Weezenbeek; Paul Nunn; Catherine J Watt; Brian G Williams; Christopher Dye
Journal:  J Infect Dis       Date:  2006-07-12       Impact factor: 5.226

Review 4.  Present aspects of bacterial resistance in tuberculosis.

Authors:  G Canetti
Journal:  Am Rev Respir Dis       Date:  1965-11

5.  Childhood drug-resistant tuberculosis in the Western Cape Province of South Africa.

Authors:  H Simon Schaaf; Ben J Marais; Anneke C Hesseling; Robert P Gie; Nulda Beyers; Peter R Donald
Journal:  Acta Paediatr       Date:  2006-05       Impact factor: 2.299

6.  A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.

Authors:  J R Bignall; A Lind; N Rist
Journal:  Bull Int Union Tuberc       Date:  1969-08

7.  Response to treatment with isoniazid plus PAS of tuberculous patients with primary isoniazid resistance.

Authors:  S P Tripathy; N K Menon; D A Mitchison; A S Narayana; P A Somasundaram; H Stott; S Velu
Journal:  Tubercle       Date:  1969-09

8.  Isoniazid pharmacokinetics in children treated for respiratory tuberculosis.

Authors:  H S Schaaf; D P Parkin; H I Seifart; C J Werely; P B Hesseling; P D van Helden; J S Maritz; P R Donald
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

9.  Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method.

Authors:  Claudio Scarparo; Paolo Ricordi; Giuliana Ruggiero; Paola Piccoli
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

10.  Response of patients infected with isoniazid-resistant tubercle bacilli to treatment with isoniazid plus PAS or isoniazid alone.

Authors:  S DEVADATTA; A L BHATIA; R H ANDREWS; W FOX; D A MITCHISON; S RADHAKRISHNA; C V RAMAKRISHNAN; J B SELKON; S VELU
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

View more
  8 in total

1.  Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.

Authors:  Paolo Denti; Anneke C Hesseling; Louvina E van der Laan; Anthony J Garcia-Prats; H Simon Schaaf; Tjokosela Tikiso; Lubbe Wiesner; Mine de Kock; Jana Winckler; Jennifer Norman; Helen McIlleron
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

2.  Synthetic EthR inhibitors boost antituberculous activity of ethionamide.

Authors:  Nicolas Willand; Bertrand Dirié; Xavier Carette; Pablo Bifani; Amit Singhal; Matthieu Desroses; Florence Leroux; Eve Willery; Vanessa Mathys; Rebecca Déprez-Poulain; Guy Delcroix; Frédéric Frénois; Marc Aumercier; Camille Locht; Vincent Villeret; Benoit Déprez; Alain R Baulard
Journal:  Nat Med       Date:  2009-05-03       Impact factor: 53.440

3.  Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis.

Authors:  Zehua Zhang; Fei Dai; Fei Luo; Min Zhong; Zhenggu Huang; Tianyong Hou; Jianzhong Xu
Journal:  J Orthop Surg Res       Date:  2014-12-03       Impact factor: 2.359

4.  Evaluation of GenoType MTBDRplus for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Karachi, Pakistan.

Authors:  Sara Siddiqui; Meredith B Brooks; Amyn A Malik; Junaid Fuad; Ahsana Nazish; Safia Bano; Mercedes C Becerra; Hamidah Hussain
Journal:  PLoS One       Date:  2019-08-19       Impact factor: 3.240

5.  Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia.

Authors:  Muluwork Getahun; Henry M Blumberg; Gobena Ameni; Dereje Beyene; Russell R Kempker
Journal:  PLoS One       Date:  2022-09-13       Impact factor: 3.752

6.  Minimal inhibitory concentrations of first-line drugs of multidrug-resistant tuberculosis isolates.

Authors:  Nicolas Schönfeld; Thorsten Bergmann; Silvan Vesenbeckh; Harald Mauch; Gudrun Bettermann; Torsten T Bauer; Holger Rüssmann
Journal:  Lung India       Date:  2012-10

7.  Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.

Authors:  Elsje Pienaar; Jennifer J Linderman; Denise E Kirschner
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

8.  Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.

Authors:  Elizabeth P Harausz; Anthony J Garcia-Prats; Stephanie Law; H Simon Schaaf; Tamara Kredo; James A Seddon; Dick Menzies; Anna Turkova; Jay Achar; Farhana Amanullah; Pennan Barry; Mercedes Becerra; Edward D Chan; Pei Chun Chan; Domnica Ioana Chiotan; Aldo Crossa; Peter C Drobac; Lee Fairlie; Dennis Falzon; Jennifer Flood; Medea Gegia; Robert M Hicks; Petros Isaakidis; S M Kadri; Beate Kampmann; Shabir A Madhi; Else Marais; Andrei Mariandyshev; Ana Méndez-Echevarría; Brittany Kathryn Moore; Parpieva Nargiza; Iveta Ozere; Nesri Padayatchi; Saleem- Ur-Rehman; Natasha Rybak; Begoña Santiago-Garcia; N Sarita Shah; Sangeeta Sharma; Tae Sun Shim; Alena Skrahina; Antoni Soriano-Arandes; Martin van den Boom; Marieke J van der Werf; Tjip S van der Werf; Bhanu Williams; Elena Yablokova; Jae-Joon Yim; Jennifer Furin; Anneke C Hesseling
Journal:  PLoS Med       Date:  2018-07-11       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.